REDWOOD CITY, Calif, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2017 financial results after market close on Thursday, November 9, 2017. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
| Live Call: | U.S. | 855 890 8665 | ||||
| International | 720 634 2938 | |||||
| Passcode | 5797258 | |||||
| Live Webcast: | Codexis IR Website | |||||
| The webcast will be archived for 30 days. | ||||||
| Replay: | U.S. | 855 859 2056 | ||||
| International | 404 537 3406 | |||||
| Passcode | 5797258 | |||||
| The replay will be available for 48 hours | ||||||
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
CONTACTS
Investors
LHA Investor Relations
Jody Cain, 310 691 7100
jcain@lhai.com